Introduction

The integration of AI into medical practice is introducing a complex new dimension to medical malpractice, shifting the traditional legal focus from a single provider to a multi-faceted chain of liability that includes physicians, AI developers, and the healthcare institutions themselves. The core of this legal evolution lies in adapting the established “standard of care” doctrine to a world where automated recommendations can influence, or even dictate, clinical decisions.

1. The Evolving Standard of Care: The Physician’s Duty in an AI-Enabled World

Physician-in-the-Loop

The “physician-in-the-loop” concept is central to the current legal framework. Courts and regulators are steadfastly reinforcing the principle that a clinician cannot delegate their ultimate responsibility to an algorithm. The standard of care now incorporates a new, critical duty: to exercise competent oversight of AI tools. This means a physician must not blindly accept an AI’s output, but instead must critically evaluate it in light of the patient’s unique clinical context and their own professional judgment.

Legislation as a Barometer

State-level laws, like California’s Physicians Make Decisions Act (SB 1120, 2024), provide a clear legal precedent. This law prohibits health plans and disability insurers from using AI as the sole arbiter of medical necessity in prior authorization decisions, mandating that a licensed physician or a qualified healthcare professional must review and approve any denial, delay, or modification of care. This directly codifies the principle that human review is non-negotiable, particularly when access to care is at stake. The law’s passage indicates a growing legislative consensus on the need for human oversight to protect patient safety.

“Reasonable Physician” Standard

While a significant body of case law on AI-related medical malpractice is still developing, legal scholars are applying existing tort principles. The question for a court would be whether a “reasonable physician” would have relied on the AI’s recommendation under the same circumstances. Factors in this analysis would likely include:

• The physician’s training and familiarity with the AI tool’s limitations.
• Whether the AI’s recommendation was a radical departure from established medical guidelines.
• The availability of human-interpretable explanations for the AI’s output.

The physician’s liability, therefore, will hinge on the diligence they exercise in their use of the technology.

2. Holding Developers Accountable: Products Liability in the Age of Algorithms

For AI developers and manufacturers, the legal exposure is shifting from a traditional software negligence framework to one more akin to products liability. This doctrine holds manufacturers liable for defective products that cause harm, regardless of fault. A plaintiff’s legal theory against an AI developer could be based on several claims:

Defective Design

This could involve an AI algorithm that is fundamentally flawed, such as one trained on a biased dataset that systematically under-diagnoses conditions in certain patient populations. The use of flawed or non-representative data could be deemed a design defect.

Failure to Warn

Developers have a duty to warn end-users about known risks and limitations of their product. If a developer fails to adequately disclose the AI’s susceptibility to certain biases, or if its performance degrades under specific conditions, they may be found liable for a failure to warn. This is particularly relevant given the “algorithmic drift” of some AI models.

Manufacturing Defect

While less common for software, this could apply to a specific instance where a deployed AI model deviates from its intended, tested version due to a deployment error or corruption, leading to a harmful outcome.

3. Institutional Negligence: The Hospital’s Duty of Care

Healthcare institutions, such as hospitals and health systems, are now a primary target for litigation in AI-related malpractice cases. Their legal exposure is based on the doctrine of institutional negligence, which holds the institution liable for its own failure to protect patient safety.

Duty to Vet and Validate

Hospitals have a duty to ensure that any AI system they purchase and deploy is suitable for their specific patient population and clinical environment. This includes conducting internal validation studies to verify the AI’s performance and to identify any biases that may not have been apparent during the developer’s pre-market testing.

Duty to Train and Monitor

The institution must provide adequate training to its staff on the proper use of AI tools, including their limitations. A failure to educate clinicians on how to appropriately supervise an AI could be considered a form of institutional negligence. Additionally, hospitals have an ongoing duty to monitor the AI’s performance post-implementation and to implement robust governance policies to ensure its safe use.

Recent Litigation

While not yet resolved in court, several high-profile lawsuits have been filed against healthcare companies alleging that they used AI to improperly deny or delay care. For example, a lawsuit filed against UnitedHealth Group in 2023 alleged that its subsidiary, Optum, used a flawed AI algorithm (naviHealth) to deny post-acute care for Medicare Advantage patients, leading to severe patient harm. These cases signal a legal trend toward holding institutions directly accountable for the adverse outcomes of their AI-driven operational and clinical decisions.

Conclusion

AI’s integration into clinical practice is reshaping liability across the healthcare spectrum. Physicians must exercise critical oversight, developers must be accountable for safe and transparent systems, and hospitals must implement robust governance for AI tools. As litigation emerges and regulators act, the law will continue to evolve. For now, the guiding principles are clear: transparency, accountability, and patient safety must remain at the center of AI-enabled healthcare.